- Home
- PKE vs AVIR Comparison
PKE vs AVIR Comparison
Compare PKE & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PKE | AVIR |
|---|---|---|
| Founded | 1954 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 463.2M | 450.9M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PKE | AVIR |
|---|---|---|
| Price | $26.62 | $5.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 273.7K | ★ 598.2K |
| Earning Date | 05-14-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ 0.37 | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $74.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.97 | $2.46 |
| 52 Week High | $29.60 | $6.45 |
Technical Indicators
Market Signals| Indicator | PKE | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 43.77 |
| Support Level | $23.29 | $3.33 |
| Resistance Level | $29.60 | $6.45 |
| Average True Range (ATR) | 1.22 | 0.27 |
| MACD | -0.16 | -0.16 |
| Stochastic Oscillator | 27.05 | 5.14 |
Price Performance
Historical ComparisonAbout PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.